Mosqueda, Salmah T.

HRN: 22-60-15  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2023
CEFUROXIME 500MG (TAB)
02/11/2023
02/18/2023
PO
500 Mg
BID
Thinly Meconium-Stained Amniotic Fluid
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive TractProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: